open access

Vol 82, No 1 (2011)
ARTICLES
Get Citation

PARP-1 activity in normal and cancerous human endometrium and its relationship with quantity of abasic sites (AP)

Krzysztof Postawski, Marta Monist, Gerard Keith
Ginekol Pol 2011;82(1).

open access

Vol 82, No 1 (2011)
ARTICLES

Abstract

Objectives: Poly (ADP-ribose) polymerase (PARP-1) is involved in the processes of DNA repair, contributing to the maintenance of genomic stability. Recent data suggest that polymerase is involved in the development of endometrial adenocarcinomas and more advanced tumors displaying lowest enzyme protein expression. Data on PARP-1 activity regarding carcinogenesis in human endometrium are scarce. That was the reason why the authors of the present work wished to investigate the enzyme activity in human uterine hormone-dependent cancer and to compare the results with those obtained for normal endometrial tissue. The next aim was to check whether enzyme activity in normal and cancerous endometrium depends on the number of AP sites, which are widely known as oxidative stress DNA damage markers and PARP-1 activity stimulators. Material and methods: Universal Colorimetric PARP Assay Kit was used to estimate the enzyme activity in units/mg protein. Apurinic sites/105 base pairs (bp) were measured by Oxidative DNA Damage Kit Quantitative. Results were calculated for 47 endometrial samples and 15 uterine adenocarcinomas specimens. Finally, the PARP-1 activity was analyzed for histological and some clinical features of neoplasms. Results and conclusions: 1. no differences in PARP-1 activity were found in non-cancerous types of human endometrium; 2. mean enzyme activity was lower in sporadic endometrial cancers than in noncancerous endometrial specimens (2.89±0.55 vs 6.39±0.06; p<0.005); 3. mean PARP-1 activity in lower grade neoplasms was higher than in G3 tumors and was lower in adenocarcinomas displaying deep uterine wall infiltration; 4. there was no relationship between PARP-1 activity and AP level.

Abstract

Objectives: Poly (ADP-ribose) polymerase (PARP-1) is involved in the processes of DNA repair, contributing to the maintenance of genomic stability. Recent data suggest that polymerase is involved in the development of endometrial adenocarcinomas and more advanced tumors displaying lowest enzyme protein expression. Data on PARP-1 activity regarding carcinogenesis in human endometrium are scarce. That was the reason why the authors of the present work wished to investigate the enzyme activity in human uterine hormone-dependent cancer and to compare the results with those obtained for normal endometrial tissue. The next aim was to check whether enzyme activity in normal and cancerous endometrium depends on the number of AP sites, which are widely known as oxidative stress DNA damage markers and PARP-1 activity stimulators. Material and methods: Universal Colorimetric PARP Assay Kit was used to estimate the enzyme activity in units/mg protein. Apurinic sites/105 base pairs (bp) were measured by Oxidative DNA Damage Kit Quantitative. Results were calculated for 47 endometrial samples and 15 uterine adenocarcinomas specimens. Finally, the PARP-1 activity was analyzed for histological and some clinical features of neoplasms. Results and conclusions: 1. no differences in PARP-1 activity were found in non-cancerous types of human endometrium; 2. mean enzyme activity was lower in sporadic endometrial cancers than in noncancerous endometrial specimens (2.89±0.55 vs 6.39±0.06; p<0.005); 3. mean PARP-1 activity in lower grade neoplasms was higher than in G3 tumors and was lower in adenocarcinomas displaying deep uterine wall infiltration; 4. there was no relationship between PARP-1 activity and AP level.
Get Citation

Keywords

PARP-1 activity human, Endometrium, uterine adenocarcinoma

About this article
Title

PARP-1 activity in normal and cancerous human endometrium and its relationship with quantity of abasic sites (AP)

Journal

Ginekologia Polska

Issue

Vol 82, No 1 (2011)

Bibliographic record

Ginekol Pol 2011;82(1).

Keywords

PARP-1 activity human
Endometrium
uterine adenocarcinoma

Authors

Krzysztof Postawski
Marta Monist
Gerard Keith

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl